Medical Advocates
HCV Infection/Disease
  Main Page
New/Noteworthy
 HCV Videos
FDA Recalls
Guidelines
General Reports
Pathogenesis
Virology  
Special Populations
Natural History
 Screening
 Risk Factors
 Clinical Variants
 Coinfections		 Extrahepatic Manifestations  
Epidemiology/Nat'l Studies
Oncology
Diagnostics
Treatment
Drugs
Patient Perspectives
Quality of Life
Prevention 
Vaccinations       
Links   

 
Home Page Main New/Newsworthy Disease Index      
Last Update:  August 31, 2010
   Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
August 2010
 

July 2010
 
Guidelines
 
      Internet Documents
 
  FULL-TEXT GUIDELINES
 Chronic Hepatitis C: Current Disease Management
 The National Institute of Diabetes and Digestive and Kidney Diseases
Guidelines
 
  Hepatitis C: What Clinicians and Other Health Professionals Need to Know
Training Module
 
 
General Reports
 
      Internet Documents
 
  FULL-TEXT REPORT
 An Interview with Melissa Palmer, MD on her book,  Dr. Melissa Palmer's Guide to
Hepatitis & Liver Disease.
 Nary G 
Thoughtleaders August 2004  Vo 2   No 1
Interview

    Journal Papers, Abstracts, and Commentaries

 
Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and
advanced liver disease.
 Delladetsima J, Alexandrou P, Giaslakiotis K,  et al
Virchows Arch. 2010 Aug 19.
 Abstract|
 
Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.
 Jafari S, Copes R, Baharlou S, et al
Int J Infect Dis. 2010 Jul 31.
Abstract

FULL-TEXT ARTICLE
 The growing contribution of hepatitis C virus infection to liver-related mortality in Scotland.
 McDonald SA, Hutchinson SJ, Bird SM,  et al
Euro Surveill. 2010 May 6;15(18). pii: 19562.
 Paper

An overview about hepatitis C: A devastating virus.
 Bostan N, Mahmood T. 
Crit Rev Microbiol. 2010 Mar 26
 Abstract

Viral hepatitis and HIV Co-Infection.
 Soriano V, Vispo E, Labarga P, et al
Antiviral Res. 2009 Oct 31.
 Abstract

Meta-Analysis: Increased Mortality Associated with Hepatitis C in HIV-Infected Persons
Is Unrelated to HIV Disease Progression.
 Chen TY, Ding EL, Seage Iii GR, Kim AY.
 Clin Infect Dis. 2009 Oct 20
 Abstract

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.
Morin T, Pariente A, Lahmek P, et al
Eur J Gastroenterol Hepatol. 2009 Sep 3.
 Abstract

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak
memory CD4 T-cell responses to hepatitis C virus.
Schnuriger A, Dominguez S, Guiguet M, et al
AIDS. 2009 Aug 25.
Abstract

Ethnicity and Body Mass Index are Associated with Hepatitis C Presentation and
Progression.
 Kallwitz ER, Layden-Almer J, Dhamija M, et al
Clin Gastroenterol Hepatol. 2009 Aug 14
 Abstract

Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase:
do they exist and is this really a group with mild disease?
 Lawson A; on behalf of the Trent Hepatitis C Study Group.
J Viral Hepat. 2009 Jul 28.
 Abstract

Effect of hepatitis C virus and its treatment on survival.
 Butt AA, Wang X, Moore CG.
Hepatology. 2009 Jul 9.
 Abstract

Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study
of patients with chronic viral C hepatitis.
 Acalovschi M, Buzas C, Radu C, Grigorescu M.
J Viral Hepat. 2009 May 26.
 Abstract

Hepatitis C virus and alcohol.
 Siu L, Foont J, Wands JR.
Semin Liver Dis. 2009 May;29(2):188-99.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Adherence to medication for chronic hepatitis C: Building on the model of human immunodeficiency
virus antiretroviral adherence research.
 Weiss JJ, Bräu N, Stivala A, et al  
Aliment Pharmacol Ther. 2009 Mar 26.
 Abstract

Hepatitis After Intravenous Injection of Sublingual Buprenorphine in Acute Hepatitis C Carriers:
Report of Two Cases of Disappearance of Viral Replication After Acute Hepatitis (May).
Peyrière H, Tatem L, Bories C, et al 
Ann Pharmacother. 2009 Apr 21.
Abstract

Transplantation of kidneys from HBV-positive or HCV-positive donors.
Xie X, Lan G, Peng L, Peng F, Wang Y, Fang C, Nie M.
 Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Mar;34(3):259-63
 Abstract

Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis
and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L, Spicher VM, Negro F, et al
 J Viral Hepat. 2009 Feb 23
 Abstract
 
FULL-TEXT ARTICLE
Evidence of recombination in intrapatient populations of hepatitis C virus.
 Sentandreu V, Jiménez-Hernández N, Torres-Puente M, et al
PLoS ONE. 2008 Sep 18;3(9):e3239.
 Paper
 
Intranasal Transmission of Hepatitis C Virus: Virological and Clinical Evidence.
 Aaron S, McMahon JM, Milano D,  et al
Clin Infect Dis. 2008 Sep 2.
 Abstract
 
Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
 Hiroishi K, Ito T, Imawari M.
 J Gastroenterol Hepatol. 2008 Aug 28.
 Abstract
 
Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
 Jonsson JR, Barrie HD, O'Rourke P, et al  
Hepatology. 2008 Mar 3;48(1):80-87.
Abstract
 
"Look, I'm fit, I'm positive and I'll be all right, thank you very much": Coping with hepatitis C treatment and
unrealistic optimism.
 Treloar C, Hopwood M. 
Psychol Health Med. 2008 May;13(3):360-6.
 Abstract
 
FULL TEXT ARTICLE
 Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of
HCV genotype.
 Abdoul H, Mallet V, Pol S, Fontanet A. 
PLoS ONE. 2008 Jun 11;3(6):e2391.
 Paper
 
Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France.
 Deuffic-Burban S, Deltenre P, Louvet A, et al
J Hepatol. 2008 May 20.
Abstract
 
Immune responses during acute and chronic infection with hepatitis C virus.
Ishii S, Koziel MJ.
Clin Immunol. 2008 May 29.
Abstract
 
Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
 Shores NJ, Maida I, Soriano V, Núňez M.
 J Hepatol. 2008 May 5.
Abstract
 
Acute hepatitis C: a systematic review.
 Kamal SM.  
Am J Gastroenterol. 2008 May;103(5):1283-97;
 Abstract
 
Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide
community-based register study.
 Duberg AS, Törner A, Daviðsdóttir L, et al
J Viral Hepat. 2008 Apr 4
Abstract
 
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral
therapy.
 Mosley JW, Operskalski EA, Tobler LH, et al 
J Viral Hepat. 2008 Feb;15(2):120-8.
 Abstract
 
Estimating past hepatitis C infection risk from reported risk factor histories: implications for
imputing age of infection and modeling fibrosis progression.
 Bacchetti P, Tien PC, Seaberg EC, et al
BMC Infect Dis. 2007 Dec 10;7(1):145
 Paper
 
FULL TEXT ARTICLE
 The hepatitis C sequence database in Los Alamos.
 Kuiken C, Hraber P, Thurmond J, Yusim K. 
Nucleic Acids Res. 2007 Nov 19
Paper
 
Spontaneous Recovery in Acute Human HCV Infection: Functional T Cell Thresholds
and Relative Importance of CD4 Help.
 Smyk-Pearson S, Tester IA, et al  
 J Virol. 2007 Nov 28
Abstract
 
Hepatitis C Virus Infection: Sexual or Non-Sexual Transmission Between Spouses?
A Case Report and Review of the Literature.
 Orlando R, Lirussi F. 
Infection. 2007 Sep 28;
 Abstract
 
HCV and diabetes A two question-based reappraisal.
Lonardo A, Carulli N, Loria P.
 Dig Liver Dis. 2007 Jul 2;
 Abstract
 
FULL TEXT PDF ARTICLE
 Alcohol and hepatitis C.
 Duggan JM, Duggan AE. 
Med J Aust. 2007 Jul 2;187(1):47-8.
 Commentary
 
Hepatitis C videoconferencing: the impact on continuing medical education for rural healthcare
providers.
 Rossaro L, Tran TP, Ransibrahmanakul K, et al 
Telemed J E Health. 2007 Jun;13(3):269-78.
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT ARTICLE
 Hepatitis C virus: Virology, diagnosis and management of antiviral therapy.
 Chevaliez S, Pawlotsky JM.
World J Gastroenterol. 2007 May 7;13(17):2461-6
 Paper
 
FULL TEXT ARTICLE
Hepatitis C virus proteins.
 Dubuisson J.
World J Gastroenterol. 2007 May 7;13(17):2406-15.
Paper
 
FULL TEXT ARTICLE
 Cell culture systems for the hepatitis C virus.
 Duverlie G, Wychowski C.
World J Gastroenterol. 2007 May 7;13(17):2442-5.
 Paper
 
Anger experiences among hepatitis C patients: relationship to depressive symptoms and
health-related quality of life.
 Dan AA, Crone C, Wise TN, Martin LM, et al
Psychosomatics. 2007 May-Jun;48(3):223-9.
 Abstract
 
Prevalence of Risk Factors for Hepatitis C Virus in HIV-Infected and HIV/Hepatitis C Virus-
Coinfected Patients.
 Bollepalli S, Mathieson K, Bay C, et al
Sex Transm Dis. 2006 Sep 28;|
 Abstract
 
Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C.
 Castera L, Constant A, Bernard PH, et al 
J Viral Hepat. 2006 Jul;13(7):482-8.
 Abstract
 
Risk factors for HIV infection among patients infected with hepatitis C virus.
 Silva AC, Barone AA.
 Rev Saude Publica. 2006 Jun;40(3):482-8.
 Abstract
 
Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-
monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.
 Thein H, Maruff P, Krahn M, et al  
HIV Med. 2007 Apr;8(3):192-202.
 Abstract
 
Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. [US]
 Campos NG, Salomon JA, Servoss JC, et al 
Am J Med. 2007 Mar;120(3):272-9.
 Abstract
 
Compensation of victims of nosocomial or post-transfusion hepatitis C virus infection. [France]
 Manaouil C, Capron D, Nguyen-Khac ER, Jarde O.  
 Gastroenterol Clin Biol. 2007 Feb;31(2):185-94.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Occult hepatitis C virus infection: A new form of hepatitis C.
 Carreño V
 World J Gastroenterol. 2006 Nov 21;12(43):6922-6925.
Paper
 
FULL-TEXT PDF ARTICLE
Correlates of HCV seropositivity among familial contacts of HCV positive patients.
 La Torre G, Miele L, Mannocci A, et al
BMC Public Health. 2006 Sep 25;6(1):237
Paper
 
Hepatitis C, metabolic syndrome, and inflammatory markers: Results from the Third National
Health and Nutrition Examination Survey [NHANES III].
 Shaheen M, Echeverry D, Oblad MG, et al   
 Diabetes Res Clin Pract. 2006 Aug 16;
 Abstract
 
Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients.
 Pastore L, Fiore JR, Tateo M, et al 
Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):217-24
 Abstract
 
Eligibility for treatment of hepatitis C virus infection among young injection drug users in
3 US cities.
 Hagan H, Latka MH, Campbell JV, et al 
Clin Infect Dis. 2006 Mar 1;42(5):669-72
 Abstract
  
Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and
HIV/HCV-co-infected veterans.
 Goulet JL, Fultz SL, McGinnis KA, Justice AC.
AIDS. 2005 Oct;19 Suppl 3:S99-S105.
 Abstract
 
Psychological implications of hepatitis C virus diagnosis.
 Gill ML, Atiq M, Sattar S, Khokhar N. 
J Gastroenterol Hepatol. 2005 Nov;20(11):1741-4
 Abstract
 
Emerging evidence of hepatitis C virus neuroinvasion.
 Lakus T, Radkowski M, Adair DM,  
AIDS. 2005 Oct;19 Suppl 3:S140-4.
 Abstract
 
FULL-TEXT REPORT
 Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.
 Ko WS, Guo CH, Yeh MS, Lin LY, et al 
World J Gastroenterol. 2005 Aug 14;11(30):4697-702
 Abstract
 
Risk factors for the acquisition of hepatitis C.
 Bergk A, Berg T, Neumann UP. 
Minerva Gastroenterol Dietol. 2005 Mar;51(1):7-1
 Abstract

FULL-TEXT REPORT
Biopsychosocial Predictors of Health-Related Quality of Life in Patients With Chronic
Hepatitis C.
 Hauser W, Zimmer C, Schiedermaier P, Grandt D.
 Psychosom Med. 2004 Nov;66(6):954-958.
Paper
 
Receiving a hepatitis C-positive diagnosis.
 Hopwood M, Treloar C.
 Intern Med J. 2004 Sep;34(9-10):526-31.
 Abstract
 
FULL-TEXT ARTICLE
Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.
 Pham TN, MacParland SA, Mulrooney PM  
J Virol. 2004 Jun;78(11):5867-74.
 Paper
 
Burden of illness of hepatitis C from a managed care organization perspective.
Armstrong EP, Charland SL.
Curr Med Res Opin. 2004 May;20(5):671-9.
 Abstract
 
Hepatitis B and C virus infection and the risk of atherosclerosis in a general population.
 Volzke H, Schwahn C, Wolff B 
Atherosclerosis. 2004 May;174(1):99-103.
Abstract
 
High body mass index is an independent risk factor for nonresponse to antiviral
treatment in chronic hepatitis C.
Bressler BL, Guindi M, Tomlinson G, Heathcote J.
Hepatology. 2003 Sep;38(3):639-44.
Abstract
 
Quality of life and cognitive function in hepatitis C at different stages
of liver disease.
Cordoba J, Flavia M, Jacas C, et al
J Hepatol. 2003 Aug;39(2):231-238.
Abstract
 
Rheumatic manifestations of hepatitis C infection.
 Vassilopoulos D, Calabrese LH.
Curr Rheumatol Rep 2003 Jun;5(3):200-4
 Abstract
 
Understudied populations with hepatitis C.
 Strader DB.
Hepatology 2002 Nov;36(5):S226-S236
 Abstract
 
Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis.
 Maillefert JF, Muller G, Falgarone G, et al
Ann Rheum Dis 2002 Jul;61(7):635-637
 Abstract
 
 
    Conference Reports, Abstracts, and Posters
 
 
What's new in hepatitis C?
V Soriano
 Ninth International Congress on Drug Therapy in HIV Infection
 PDF Abstract

CD8-independent T cell populations dominate the immune response against HCV
 V. Kasprowicz , Y.-H. Kang  , B.E. Nolan , et al
 (XVII International AIDS Conference)
Abstract
Pathogenesis
 
      Journal Papers, Abstracts, and Commentaries
 
 
Virology and pathogenesis of hepatitis C virus recurrence.
 Ramírez S, Pérez-Del-Pulgar S, Forns X.  
Liver Transpl. 2008 Oct;14 Suppl 2:S27-35.
 Abstract

Pathogenesis of hepatitis C virus infection.
 Kohla M, Bonacini M. et al 
Minerva Gastroenterol Dietol. 2006 Jun;52(2):107-23
 Abstract
 
    Conference Reports, Abstracts, and Posters
 
  Immunopathogenesis of Acute and Chronic Viral Hepatitis C
 B Rehermann
 (14 CROI)
 Abstract
Virology
 
      Journal Papers, Abstracts, and Commentaries
 
 
Sustained virological response according to the type of early virological response in
HCV and HCV/HIV.
Lerias de Almeida PR, Alves de Mattos A, Valle Tovo C.
Ann Hepatol. 2010 Jun 1;9(2):150-155.
 Abstract

Hepatitis C Viral Kinetics in Special Populations.
Dahari H, Layden-Almer JE, Perelson AS, Layden TJ.
 Curr Hepat Rep. 2008;7(3):97-105.
 Abstract
 
Virology and pathogenesis of hepatitis C virus recurrence.
 Ramírez S, Pérez-Del-Pulgar S, Forns X.  
 Liver Transpl. 2008 Oct;14 Suppl 2:S27-35.
 Abstract
 
FULL-TEXT ARTICLE
Molecular Virology of Hepatitis C Virus (HCV): 2006 Update.
 Brass V, Moradpour D, Blum HE.
Int J Med Sci. 2006;3(2):29-34
 Paper

Hepatitis C-virus - virus kinetics and resistance mechanisms
 Herrmann E, Sarrazin C.
Z Gastroenterol. 2004 May;42(5):387-96
 Abstract
 
      Conference Reports, Abstracts, and Posters
 
  POSTER
 Hepatitis C Viral Kinetics: Changes in HCV Viral Load during the First 2 Weeks Are
Associated with Virologic Response but Are Not Affected by HIV Status
 M Jain, J Shelton, A Reeck, et al
 (14 CROI)
PDF Poster     Abstract
 
POSTER
 Genetic and Phenotypic Structure of Hepatitis C Virus NS3/4 Protease Quasispecies
S Franco, M Parera, E Aparicio. et al
 (14 CROI)
PDF Poster     Abstract
 
POSTER
 Analysis of the Hepatitis C Virus Antigen-specific T-cell Receptor Repertoire during Acute Infection
E Patterson, A Cox,  S Ray
 (14 CROI)
PDF Poster     Abstract
Natural History/Clinical Course
 
      Journal Papers, Abstracts, and Commentaries
 
 
Ethnicity and Body Mass Index are Associated with Hepatitis C Presentation and
Progression.
 Kallwitz ER, Layden-Almer J, Dhamija M, et al
Clin Gastroenterol Hepatol. 2009 Aug 14
 Abstract

The natural history of recurrent hepatitis C and what influences this.
Gane EJ.
 Liver Transpl. 2008 Oct;14 Suppl 2:S36-44
 Abstract
 

Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.
 Missiha SB, Ostrowski M, Heathcote EJ.
Gastroenterology. 2008 May;134(6):1699-714
 Abstract
 
Clinical course of hepatitis C virus infection in renal transplant recipients.
 Savas N, Ocal S, Colak T, et al
Transplant Proc. 2007 May;39(4):984-6.
 Abstract
 
FULL-TEXT ARTICLE
 The natural history of hepatitis C virus (HCV) infection.
 Chen SL, Morgan TR.
Int J Med Sci. 2006;3(2):47-52.
 Paper
 
Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to
hepatocellular carcinoma.
 Leone N, Rizzetto M. 
Minerva Gastroenterol Dietol. 2005 Mar;51(1):31-46.
 Abstract

Hepatitis C and Progression of HIV Disease.
 Sulkowski MS, Moore RD, Mehta SH,  et al.
JAMA 2002 Jul 10;288(2):199-206
 Abstract

Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the
natural course of hepatitis C virus infection in the general population.
 Kondili LA, Chionne P, Costantino A, et al
 Gut 2002 May;50(5):693-6
 Abstract
 
FULL-TEXT ARTICLE
Clinical course of hepatitis C virus during the first decade of infection: cohort study
Harris HW, Ramsay ME,  Andrews N,  Eldridge KP
 BMJ 2002; 324: 450.
 Paper
 
Is severe liver disease a common outcome for people with chronic hepatitis C?
 Dore GJ, Freeman AJ, Law M, Kaldor J.
 J Gastroenterol Hepatol 2002 Apr;17(4):423-30
Abstract
 

      Conference Reports, Abstracts, and Posters

  CONFERENCE PRESENTATION
 The Course and Outcome of Hepatitis C
 Hoofnagle JH
 [NIH Consensus Development Conference on Management of Hepatitis C: 2002]
 Report
   
  CONFERENCE PRESENTATION
 Natural History of Chronic Hepatitis C
 Seeff LB
[NIH Consensus Development Conference on Management of Hepatitis C: 2002]
Report
Patient Perspectives
 
      Journal Papers, Abstracts, and Commentaries
 
 
Quality-of-Life Tradeoffs for Hepatitis C Treatment: Do Patients and Providers Agree?
Schackman BR, Teixeira PA, Weitzman G, et al
 Med Decis Making. 2008 Mar 18 |
 Abstract
 
Communicating about Alcohol Consumption to Nonharmful Drinkers with Hepatitis C:
Patient and Provider Perspectives.
 Blixen CE, Webster NJ, Hund AJ, et al 
J Gen Intern Med. 2008 Jan
 Abstract

What do patients consider when making decisions about treatment for hepatitis C?
 Fraenkel L, McGraw S, Wongcharatrawee S, et al 
Am J Med. 2005 Dec;118(12):1387-91.
Abstract

      Conference Reports, Abstracts, and Posters

  CONFERENCE PRESENTATION
 The Course and Outcome of Hepatitis C
 Hoofnagle JH
 [NIH Consensus Development Conference on Management of Hepatitis C: 2002]
 Report
   
  CONFERENCE PRESENTATION
 Natural History of Chronic Hepatitis C
 Seeff LB
[NIH Consensus Development Conference on Management of Hepatitis C: 2002]
Report
Quality of Life
 
      Journal Papers, Abstracts, and Commentaries
 
 
Sustained Responders Have Better Quality of Life and Productivity Compared With
Treatment Failures Long After Antiviral Therapy for Hepatitis C.
John-Baptiste AA, Tomlinson G, Hsu PC, et al
Am J Gastroenterol. 2009 Jun 30.
Abstract

Quality-of-Life Tradeoffs for Hepatitis C Treatment: Do Patients and Providers Agree?
 Schackman BR, Teixeira PA, Weitzman G, et a
Med Decis Making. 2008 Mar 18
Abstract

Alcohol and Sexual HIV Risk Behavior Among Problem Drinking Men Who Have Sex With Men:
An Event Level Analysis of Timeline Followback Data.
Irwin TW, Morgenstern J, Parsons JT, et al   
AIDS Behav. 2006 Feb 16;
 Abstract
Vaccinations
 
      Journal Papers, Abstracts, and Commentaries
 
 
"Fitness for duty": Social, organisational and structural influences on the design and conduct
of candidate hepatitis C vaccine trials involving people who inject drugs.
 Treloar C, Byron P, McCann P, Maher L.
Vaccine. 2010 Jun 7
 Abstract

FULL-TEXT ARTICLE
Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections:
A review of the evidence and current recommendations.
 Buxton JA, Kim JH.
Can J Infect Dis Med Microbiol. 2008 Mar;19(2):197-202
 Paper

Home Page Main New/Newsworthy Disease Index      

Hepatitis C Main Page